These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7779414)

  • 1. Are direct measures of tumor oxygenation reflective of changes in tumor radiosensitivity following oxygen manipulation?
    Fenton BM; Siemann DW
    Acta Oncol; 1995; 34(3):307-11. PubMed ID: 7779414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of carbogen and nicotinamide on intravascular oxyhaemoglobin saturations in SCCVII and KHT murine tumours.
    Fenton BM
    Br J Cancer; 1995 May; 71(5):945-9. PubMed ID: 7734318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The radiation response of KHT sarcomas following nicotinamide treatment and carbogen breathing.
    Siemann DW; Horsman MR; Chaplin DJ
    Radiother Oncol; 1994 May; 31(2):117-22. PubMed ID: 8066190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of carbogen plus fractionated irradiation on KHT tumor oxygenation.
    Fenton BM
    Radiother Oncol; 1997 Aug; 44(2):183-90. PubMed ID: 9288848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen.
    Dorie MJ; Menke D; Brown JM
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):145-50. PubMed ID: 8270435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micro-regional mapping of HbO2 saturations and blood flow following nicotinamide administration.
    Fenton BM; Boyce DJ
    Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):459-62. PubMed ID: 8005799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of combined nicotinamide and carbogen treatments in human tumour xenografts: oxygenation and tumour control studies.
    Stüben G; Stuschke M; Knühmann K; Horsman MR; Sack H
    Radiother Oncol; 1998 Aug; 48(2):143-8. PubMed ID: 9783885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of tumor oxygenation by mild hyperthermia.
    Song CW; Park H; Griffin RJ
    Radiat Res; 2001 Apr; 155(4):515-28. PubMed ID: 11260653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of tumor perfusion and oxygenation by carbogen and nicotinamide during single- and multifraction irradiation.
    Fenton BM; Lord EM; Paoni SF
    Radiat Res; 2000 Jan; 153(1):75-83. PubMed ID: 10630980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.
    Chaplin DJ; Horsman MR; Siemann DW
    Br J Cancer; 1993 Aug; 68(2):269-73. PubMed ID: 8347481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide: therapeutic gain comparisons for fractionated x-ray schedules.
    Rojas A; Vojnovic B; Johns H; Joiner MC; Martindale C; Fowler JF; Denekamp J
    Radiother Oncol; 1996 Apr; 39(1):53-64. PubMed ID: 8735494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.
    Chaplin DJ; Horsman MR; Aoki DS
    Br J Cancer; 1991 Jan; 63(1):109-13. PubMed ID: 1846549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosensitization of two murine tumours with mild temperature hyperthermia and carbogen breathing.
    Griffin RJ; Okajima K; Ogawa A; Song CW
    Int J Radiat Biol; 1999 Oct; 75(10):1299-306. PubMed ID: 10549607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of micro-regional heterogeneities in tumor oxygenation using intravascular HbO2 saturations.
    Fenton BM; Raubertas RF; Boyce DJ
    Radiat Res; 1995 Jan; 141(1):49-56. PubMed ID: 7997514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer.
    Kaanders JH; Pop LA; Marres HA; Liefers J; van den Hoogen FJ; van Daal WA; van der Kogel AJ
    Radiother Oncol; 1998 Aug; 48(2):115-22. PubMed ID: 9783882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen and nicotinamide.
    Droller MJ
    J Urol; 2000 May; 163(5):1600. PubMed ID: 10798919
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of flunarizine on micro-regional distributions of intravascular HbO2 saturations in RIF-1 and KHT sarcomas.
    Fenton BM; Sutherland RM
    Int J Radiat Oncol Biol Phys; 1992; 22(3):447-50. PubMed ID: 1735676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosensitization of SCCVII tumours and normal tissues by nicotinamide and carbogen: analysis by micronucleus assay.
    Ono K; Masunaga S; Akuta K; Akaboshi M; Abe M
    Radiother Oncol; 1993 Aug; 28(2):162-7. PubMed ID: 8248558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome and tumour microenvironmental effects of accelerated radiotherapy with carbogen and nicotinamide.
    Bussink J; Kaanders JH; Van der Kogel AJ
    Acta Oncol; 1999; 38(7):875-82. PubMed ID: 10606417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 31P NMR spectroscopy and HbO2 cryospectrophotometry in prediction of tumor radioresistance caused by hypoxia.
    Rofstad EK; DeMuth P; Fenton BM; Ceckler TL; Sutherland RM
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):919-23. PubMed ID: 2703397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.